Royalty Pharma plc (RPRX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.78 | -6.8% |
| 2024 | $1.91 | -24.5% |
| 2023 | $2.53 | +2430.0% |
| 2022 | $0.10 | -93.3% |
| 2021 | $1.49 | +12.9% |
| 2020 | $1.32 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $1.78 | -6.8% |
| 2024 | $1.91 | -24.5% |
| 2023 | $2.53 | +2430.0% |
| 2022 | $0.10 | -93.3% |
| 2021 | $1.49 | +12.9% |
| 2020 | $1.32 | — |